# Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis

> **NCT00914368** · PHASE2 · COMPLETED · sponsor: **Uppsala University** · enrollment: 450 (estimated)

## Conditions studied

- Coronary Artery Disease
- Myocardial Infarction
- Stent Thrombosis
- Heart Diseases
- Acute Coronary Syndrome

## Interventions

- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT00914368
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2010-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00914368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00914368, "Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00914368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*